April 27 (Reuters) - OpenAI has fallen short of its goals for new users and revenue in recent months, sparking concern among some company leaders over ‌whether it can support its extensive data-center ...

College grads are launching their careers in one of the worst job markets in years. The unemployment rate for recent college grads reached 9.7% as of September 2025, the same as for 20- to ...

A report on how COVID-19 vaccines reduced the risk of hospital visits has been blocked from publication in the CDC's Morbidity and Mortality Weekly Report, despite being vetted through a scientific ...

A nuclear physicist and MIT professor fatally shot outside his Massachusetts residence. A retired Air Force general missing from his New Mexico home. An aerospace engineer who disappeared during a ...

SANTA FE — For the last three decades, the ranks of New Mexico independent voters have been growing at a more rapid rate than registered Democrats or Republicans. But that trend has accelerated in ...

The judge said President Trump had not “plausibly alleged” that The Journal published the article with actual malice. By Katie Robertson A federal judge on Monday dismissed President Trump’s $10 ...

The Economic Report of the President is prepared annually by the Council of Economic Advisers, providing a comprehensive review of the past year’s economic policies and their impact on current and ...

The United States is in a period with a “persistence of diminished democracy,” according to a report that will be released on Tuesday. It’s the third study released in the last week that concludes ...

Phase 2/3 Duravelo-2 pivotal trial evaluating zelenectide pevedotin (zelenectide) plus pembrolizumab in metastatic urothelial cancer (mUC) successfully identifies 6mg/m 2 zelenectide two weeks on, one ...

At least 61 of the made-up case reports were unwittingly cited in other peer-reviewed medical journals, creating hundreds more errors. Reading time 3 minutes A journal focused on child health and ...

Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to dramatically improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and ...

- PDUFA target action date of June 30, 2026 for veligrotug for thyroid eye disease (TED); U.S. commercial preparations on track to support anticipated launch - - Marketing Authorization Application ...